Tom Coll Quoted in Article on Current Biotech IPO Market (The Scientist)

Tom Coll, partner and chair of Cooley's San Diego Business and Technology practice group, was quoted in an article on the current biotech IPO market.

View the article here.
Related Contacts
Tom Coll Partner San Diego